Esmolol contraindications: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Redirected page to Esmolol#Contraindications)
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Esmolol#Contraindications]]
{{Esmolol}}
{{CMG}}; {{AE}} {{AZ}}; {{AK}}
 
==Contraindications==
 
BREVIBLOC (Esmolol Hydrochloride) is contraindicated in patients with:
 
* <u>'''Severe sinus bradycardia'''</u>: May precipitate or worsen [[bradycardia]] resulting in [[cardiogenic shock]] and [[cardiac arrest]].
* <u>'''Heart block greater than first degree'''</u>: [[Second degree AV block|Second]]- or [[Third degree AV block|third-degree atrioventricular block]] may precipitate or worsen [[bradycardia]] resulting in [[cardiogenic shock]] and [[cardiac arrest]].
* <u>'''Sick sinus syndrome'''</u>: May precipitate or worsen [[bradycardia]] resulting in [[cardiogenic shock]] and [[cardiac arrest]]
* <u>'''Decompensated heart failure'''</u>: May worsen [[heart failure]]
* <u>'''Cardiogenic shock'''</u>: May precipitate further cardiovascular collapse and cause [[cardiac arrest]]
* IV administration of cardiodepressant [[calcium-channel antagonist]]s (e.g., [[verapamil]]) and BREVIBLOC in close proximity (i.e., while cardiac effects from the other are still present); fatal [[cardiac arrest]]s have occurred in patients receiving BREVIBLOC and intravenous verapamil
* <u>'''Pulmonary hypertension'''</u>: May precipitate cardiorespiratory compromise.
* <u>'''Hypersensitivity reactions'''</u>, including [[anaphylaxis]], to esmolol or any of the inactive ingredients of the product ([[cross-sensitivity]] between [[beta blocker]]s is possible).<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = BREVIBLOC (ESMOLOL HYDROCHLORIDE) INJECTION [BAXTER HEALTHCARE CORPORATION] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=595cc3d5-1306-4828-aefa-5595219ffd62 | publisher =  | date =  | accessdate = }}</ref>
 
==References==
{{Reflist}}
 
{{FDA}}


[[Category:Beta blockers]]
[[Category:Cardiovascular Drugs]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]
[[Category:Drugs]]

Latest revision as of 19:36, 21 July 2014